应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MRNS Marinus Pharmaceuticals
休市中 08-23 16:00:00 EDT
1.30
-0.02
-1.52%
盘后
1.30
+0.00
0.00%
19:55 EDT
最高
1.38
最低
1.29
成交量
40.17万
今开
1.34
昨收
1.32
日振幅
6.81%
总市值
7,161万
流通市值
4,951万
总股本
5,508万
成交额
53.37万
换手率
1.05%
流通股本
3,809万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Marinus Pharmaceuticals, Inc.盘中异动 急速上涨5.56%报1.33美元
自选股智能写手 · 08-20
Marinus Pharmaceuticals, Inc.盘中异动 急速上涨5.56%报1.33美元
Marinus Pharmaceuticals, Inc.2024财年第二财季实现净利润-35.83百万美元,同比减少12.21%
自选股智能写手 · 08-19
Marinus Pharmaceuticals, Inc.2024财年第二财季实现净利润-35.83百万美元,同比减少12.21%
Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.43%报1.16美元
自选股智能写手 · 08-15
Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.43%报1.16美元
Marinus Pharmaceuticals, Inc.盘中异动 大幅跳水5.05%
自选股智能写手 · 08-14
Marinus Pharmaceuticals, Inc.盘中异动 大幅跳水5.05%
Marinus Pharmaceuticals Inc 报告截至 6 月的季度业绩 - 收益摘要
Reuters · 08-13
Marinus Pharmaceuticals Inc 报告截至 6 月的季度业绩 - 收益摘要
Marinus Pharmaceuticals, Inc.盘中异动 快速下跌5.28%报1.17美元
自选股智能写手 · 08-13
Marinus Pharmaceuticals, Inc.盘中异动 快速下跌5.28%报1.17美元
BUZZ--美国股票走势-Apollomics、Syros Pharmaceuticals、Buzzfeed
Reuters · 08-13
BUZZ--美国股票走势-Apollomics、Syros Pharmaceuticals、Buzzfeed
BUZZ-Marinus Pharma 第二季度收入不及预期,业绩下滑
Reuters · 08-13
BUZZ-Marinus Pharma 第二季度收入不及预期,业绩下滑
Marinus Pharmaceuticals Inc 预计每股亏损59美分 - 财报前瞻
Reuters · 08-10
Marinus Pharmaceuticals Inc 预计每股亏损59美分 - 财报前瞻
Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.17%报1.22美元
自选股智能写手 · 08-08
Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.17%报1.22美元
Marinus Pharmaceuticals, Inc.盘中异动 大幅上涨5.22%
自选股智能写手 · 08-07
Marinus Pharmaceuticals, Inc.盘中异动 大幅上涨5.22%
Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.45%
自选股智能写手 · 08-06
Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.45%
Marinus Pharmaceuticals, Inc.盘中异动 早盘急速下挫7.69%报1.20美元
自选股智能写手 · 08-05
Marinus Pharmaceuticals, Inc.盘中异动 早盘急速下挫7.69%报1.20美元
Marinus Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.00%报1.33美元
自选股智能写手 · 08-02
Marinus Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.00%报1.33美元
Marinus Pharmaceuticals, Inc.盘中异动 临近午盘大幅跳水5.24%
自选股智能写手 · 07-29
Marinus Pharmaceuticals, Inc.盘中异动 临近午盘大幅跳水5.24%
Marinus Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.41%
自选股智能写手 · 07-25
Marinus Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.41%
Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.42%报1.40美元
自选股智能写手 · 07-17
Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.42%报1.40美元
Marinus Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.67%报1.49美元
自选股智能写手 · 07-16
Marinus Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.67%报1.49美元
Marinus Pharmaceuticals, Inc.盘中异动 大幅上涨5.69%报1.30美元
自选股智能写手 · 07-11
Marinus Pharmaceuticals, Inc.盘中异动 大幅上涨5.69%报1.30美元
Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.60%报1.32美元
自选股智能写手 · 07-10
Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.60%报1.32美元
加载更多
公司概况
公司名称:
Marinus Pharmaceuticals
所属市场:
NASDAQ
上市日期:
--
主营业务:
Marinus Pharmaceuticals, Inc.于2003年8月14日在特拉华州成立。该公司是一家临床阶段生物制药公司,专注于开发创新性神经精神疗法并将其商业化。该公司的临床阶段候选产品甘纳索龙是一种小分子,它是异孕烯醇的合成类似物,异孕烯醇是一种在中枢神经系统中产生的内源性神经甾体,调节大脑神经递质γ-氨基丁酸(GABA)。该公司对加那索龙的主要适应症是作为一种辅助或附加疗法,用于治疗成人癫痫患者部分发作(也称为局灶性发作)。该公司已在147名局灶性发作癫痫患者中完成了一项2期临床试验,表明与添加安慰剂的患者相比,在用药方案中添加加那索龙的患者癫痫发作率显著降低。Marinus Pharmaceuticals目前正在招募患者参加一项随机的2b期临床试验,该公司打算扩大该试验,以便在向美国食品和药物管理局(FDA)或欧洲药品管理局(EMA)提交的关于加那索龙治疗癫痫的注册文件中,作为其充分且受控的临床试验之一。
发行价格:
--
{"stockData":{"symbol":"MRNS","market":"US","secType":"STK","nameCN":"Marinus Pharmaceuticals","latestPrice":1.3,"timestamp":1724443200000,"preClose":1.32,"halted":0,"volume":401730,"hourTrading":{"tag":"盘后","latestPrice":1.3,"preClose":1.3,"latestTime":"19:55 EDT","volume":1647,"amount":2156.6337,"timestamp":1724457338206},"delay":0,"floatShares":38087940,"shares":55084038,"eps":-2.658365,"marketStatus":"休市中","marketStatusCode":7,"change":-0.02,"latestTime":"08-23 16:00:00 EDT","open":1.34,"high":1.3799,"low":1.29,"amount":533667.37179,"amplitude":0.068106,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.658365,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1406779200000,"adjPreClose":1.32,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.3,"preClose":1.3,"latestTime":"19:55 EDT","volume":1647,"amount":2156.6337,"timestamp":1724457338206},"volumeRatio":1.800602603377473,"impliedVol":0.5383,"impliedVolPercentile":0.1786},"requestUrl":"/m/hq/s/MRNS","defaultTab":"news","newsList":[{"id":"2460069998","title":"Marinus Pharmaceuticals, Inc.盘中异动 急速上涨5.56%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460069998","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460069998?lang=zh_cn&edition=full","pubTime":"2024-08-20 03:56","pubTimestamp":1724097385,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日03时56分,Marinus Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.56%。截至发稿,该股报1.33美元/股,成交量15.4937万股,换手率0.28%,振幅5.52%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.99%。其相关个股中,Nucana Plc、Alzamend Neuro, Inc.、Virax Biolabs Group Limited涨幅较大,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为9566.01%、3950.01%、1351.59%,振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Nucana Plc,振幅分别为457.87%、220.18%、211.14%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003562597199322&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003562597199322&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2460710887","title":"Marinus Pharmaceuticals, Inc.2024财年第二财季实现净利润-35.83百万美元,同比减少12.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460710887","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460710887?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:03","pubTimestamp":1723997007,"startTime":"0","endTime":"0","summary":"8月19日,Marinus Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第二财季净利润为-35.83百万美元,同比减少12.21%;其中营业收入为8.06百万美元,同比增加32.57%,每股基本收益为-0.63美元。机构评级:截至2024年8月19日,当前有9家机构对Marinus Pharmaceuticals, Inc.目标价做出预测,其中目标均价为6.67美元,其中最低目标价为2.00美元,最高目标价为13.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900034495a38607&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900034495a38607&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS"],"gpt_icon":0},{"id":"2459475495","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.43%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459475495","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459475495?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:14","pubTimestamp":1723731271,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时14分,Marinus Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.43%。截至发稿,该股报1.16美元/股,成交量5.0963万股,换手率0.09%,振幅2.72%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,Cingulate Inc.、Tempest Therapeutics, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃,换手率分别为5340.55%、1925.52%、427.57%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Cingulate Inc.、Tempest Therapeutics, Inc.,振幅分别为103.98%、58.54%、55.46%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522143198e350b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522143198e350b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2459445707","title":"Marinus Pharmaceuticals, Inc.盘中异动 大幅跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459445707","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459445707?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:36","pubTimestamp":1723642608,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时36分,Marinus Pharmaceuticals, Inc.股票出现波动,股价急速下跌5.05%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.46%。其相关个股中,Conduit Pharmaceuticals Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cormedix Inc.涨幅较大,Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.、Tc Biopharm Plc较为活跃,换手率分别为55.61%、44.47%、10.33%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Seastar Medical Holding Corp C/Wts 28/10/2027 、Conduit Pharmaceuticals Inc.,振幅分别为44.00%、21.94%、17.45%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务,即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081421364897198b85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081421364897198b85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2459024729","title":"Marinus Pharmaceuticals Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459024729","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459024729?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:22","pubTimestamp":1723558921,"startTime":"0","endTime":"0","summary":" * Marinus Pharmaceuticals Inc 报告,截至6月底的季度调整后每股亏损60美分,高于去年同期的每股-61美分。11 位分析师对该季度的平均预期是每股亏损 59 美分。华尔街预期为每股-68美分至-52美分。* 营收同比增长 32.2%,达到 804 万美元;分析师预期为 950 万美元。* Marinus Pharmaceuticals Inc公布的本季度每股收益为亏损63美分。* Marinus Pharmaceuticals Inc本季度股价上涨了5.1%,今年迄今为止亏损了88.7%。华尔街对 Marinus Pharmaceuticals Inc 的 12 个月目标价中位数为 7.00 美元。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Marinus Pharmaceuticals Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2459901979","title":"Marinus Pharmaceuticals, Inc.盘中异动 快速下跌5.28%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459901979","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459901979?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:31","pubTimestamp":1723555870,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时31分,Marinus Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.28%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,冠科美博、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Genprex, Inc.、冠科美博、Psyence Biomedical Ltd.较为活跃,换手率分别为106.67%、64.16%、18.33%,振幅较大的相关个股有冠科美博、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Virpax Pharmaceuticals, Inc.,振幅分别为18.70%、10.94%、7.69%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813213111aefe9ee4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813213111aefe9ee4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2459905783","title":"BUZZ--美国股票走势-Apollomics、Syros Pharmaceuticals、Buzzfeed","url":"https://stock-news.laohu8.com/highlight/detail?id=2459905783","media":"Reuters","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459905783?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:14","pubTimestamp":1723554893,"startTime":"0","endTime":"0","summary":"** 西方石油公司 :盘前下跌 1.9** Devon Energy Corp :盘前下跌 0.1** EQT Corp :盘前下跌 0.3%BUZZ - BMO 下调了石油和天然气生产商的目标价 ** Uranium Energy Corp :盘前上涨1.0%BUZZ - 怀俄明州重启生产后上涨 ** 星巴克 :盘前上涨14.2%BUZZ--任命Chipotle的顶头上司Brian Niccol为首席执行官后跳涨 ** Syros Pharmaceuticals :盘前下跌 61.9%BUZZ - 血液癌症治疗组合在研究中 \"不太可能成功\",导致其下滑 ** Hudbay Minerals Inc :盘前下跌4.2%BUZZ - 因第二季度亏损扩大而下跌 ** Apollomics Inc :盘前上涨 120.3%BUZZ - 因癌症治疗研究的初步数据良好而上涨","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVN","BK4570","LU0211328371.USD","SAVA","BK4077","LU1551013425.SGD","NOVA","LU0980610538.SGD","LU2756315664.SGD","BK4023","LU1674673691.USD","LU1778281490.HKD","LUNR","BK4592","GB00BDT5M118.USD","HLT","APLM","LU0942090050.USD","EQT","SG9999013486.USD","LU2211817866.USD","LU1674673428.USD","CVX","BAX","LU1074936037.SGD","IE00B19Z4B17.USD","LU0354030438.USD","MRNS","DE","JBLU","WULF","GCTS","SYRS","RILY","SBUX","LU0323240290.USD","BK4585","HD","LU1201861249.SGD","LU0079474960.USD","LU0211327993.USD","NVAX","BK4142","BK4587","LU0868494708.USD","SG9999014484.SGD","BK4588","SG9999002679.SGD","LU0251143029.SGD","BZFD"],"gpt_icon":1},{"id":"2459972059","title":"BUZZ-Marinus Pharma 第二季度收入不及预期,业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2459972059","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459972059?lang=zh_cn&edition=full","pubTime":"2024-08-13 20:08","pubTimestamp":1723550927,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 8月13日 - ** 制药商Marinus Pharmaceuticals 股价盘前下跌2.9%至1.20美元** 该公司第二季度利润为806万美元,低于华尔街预计的950万美元 - LSEG ** MRNS 第二季度每股亏损 63 美分,比去年同期每股亏损 61 美分有所扩大。** 截至上次收盘,股价累计下跌 88.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","MRNS","BK4007"],"gpt_icon":0},{"id":"2458510525","title":"Marinus Pharmaceuticals Inc 预计每股亏损59美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458510525","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458510525?lang=zh_cn&edition=full","pubTime":"2024-08-10 02:36","pubTimestamp":1723228572,"startTime":"0","endTime":"0","summary":" * Marinus Pharmaceuticals Inc 将于8月13日发布截至2024年6月30日的季度业绩报告,预计该公司的季度收入将有所增长。* LSEG分析师对Marinus Pharmaceuticals Inc的平均预期为每股亏损59美分。* 华尔街对 Marinus Pharmaceuticals Inc 的 12 个月目标价中位数为 7.00 美元,高于上一次收盘价 1.25 美元。8月9日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Marinus Pharmaceuticals Inc 预计每股亏损59美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNS"],"gpt_icon":0},{"id":"2457485013","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.17%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457485013","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457485013?lang=zh_cn&edition=full","pubTime":"2024-08-08 22:56","pubTimestamp":1723129007,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日22时56分,Marinus Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.17%。截至发稿,该股报1.22美元/股,成交量5.3796万股,换手率0.10%,振幅4.31%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为2.63%。其相关个股中,Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃,换手率分别为330.33%、282.72%、177.51%,振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.,振幅分别为74.12%、54.41%、42.63%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808225647a1d427d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808225647a1d427d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2457842217","title":"Marinus Pharmaceuticals, Inc.盘中异动 大幅上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457842217","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457842217?lang=zh_cn&edition=full","pubTime":"2024-08-07 22:08","pubTimestamp":1723039704,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日22时08分,Marinus Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.22%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.28%。其相关个股中,G1 Therapeutics, Inc.、Aditxt, Inc.、Alpha Tau Medical Ltd C/Wts 涨幅较大,Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.较为活跃,换手率分别为1197.83%、83.99%、48.21%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Aditxt, Inc.、Salarius Pharmaceuticals, Inc.,振幅分别为69.66%、52.16%、25.27%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务,即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807220825aefdbb52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807220825aefdbb52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2457533021","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457533021","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457533021?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:31","pubTimestamp":1722954691,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日22时31分,Marinus Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.45%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.51%。其相关个股中,Vbi Vaccines, Inc.、Alpha Tau Medical Ltd C/Wts 、Scorpius Holdings, Inc.涨幅较大,Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为1124.08%、988.78%、331.45%,振幅较大的相关个股有Vbi Vaccines, Inc.、Anew Medical Inc C/Wts 21/06/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为168.52%、70.73%、52.93%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806223131af963542&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806223131af963542&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2457347778","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘急速下挫7.69%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457347778","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457347778?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864767,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分,Marinus Pharmaceuticals, Inc.股票出现波动,股价快速跳水7.69%。截至发稿,该股报1.20美元/股,成交量2.8758万股,换手率0.05%,振幅1.15%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.36%。其相关个股中,Zevra Therapeutics, Inc.、Alzamend Neuro, Inc.、Cns Pharmaceuticals, Inc.涨幅较大,Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃,换手率分别为984.93%、36.15%、13.54%,振幅较大的相关个股有Vor Biopharma Inc.、Compass Therapeutics, Inc.、Neurobo Pharmaceuticals, Inc.,振幅分别为13.04%、12.19%、11.29%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213247957f2e65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213247957f2e65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2456282779","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.00%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456282779","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456282779?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:51","pubTimestamp":1722606670,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时51分,Marinus Pharmaceuticals, Inc.股票出现异动,股价大幅下跌5.00%。截至发稿,该股报1.33美元/股,成交量8.775万股,换手率0.16%,振幅2.14%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.23%。其相关个股中,Exicure, Inc.、Dermata Therapeutics, Inc.、Os Therapies Incorporated涨幅较大,Dermata Therapeutics, Inc.、Exicure, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为1403.70%、511.59%、43.39%,振幅较大的相关个股有Os Therapies Incorporated、Exicure, Inc.、Dermata Therapeutics, Inc.,振幅分别为54.19%、49.18%、37.50%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802215110941fd937&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802215110941fd937&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2455667147","title":"Marinus Pharmaceuticals, Inc.盘中异动 临近午盘大幅跳水5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455667147","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455667147?lang=zh_cn&edition=full","pubTime":"2024-07-29 23:36","pubTimestamp":1722267418,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日23时36分,Marinus Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.24%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。其相关个股中,Lipella Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.涨幅较大,Lipella Pharmaceuticals Inc.、Salarius Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为2152.48%、716.53%、227.20%,振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为151.15%、75.11%、57.78%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务,即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729233659aefbfcf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729233659aefbfcf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2454831464","title":"Marinus Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454831464","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454831464?lang=zh_cn&edition=full","pubTime":"2024-07-25 02:38","pubTimestamp":1721846312,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日02时38分,Marinus Pharmaceuticals, Inc.股票出现异动,股价大幅下跌5.41%。截至发稿,该股报1.40美元/股,成交量16.3445万股,换手率0.30%,振幅5.41%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.31%。其相关个股中,Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.涨幅较大,Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃,换手率分别为8994.00%、1527.98%、713.14%,振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ,振幅分别为191.54%、99.60%、75.86%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250238329681fe4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250238329681fe4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2452169105","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.42%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452169105","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452169105?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:35","pubTimestamp":1721230523,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时35分,Marinus Pharmaceuticals, Inc.股票出现波动,股价快速下跌5.42%。截至发稿,该股报1.40美元/股,成交量15.9355万股,换手率0.29%,振幅4.75%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为2.04%。其相关个股中,Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃,换手率分别为3038.95%、1326.43%、280.07%,振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为76.39%、46.25%、43.75%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172335239681db4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172335239681db4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2451919144","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.67%报1.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451919144","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451919144?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:11","pubTimestamp":1721142704,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日23时11分,Marinus Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.67%。截至发稿,该股报1.49美元/股,成交量20.3429万股,换手率0.37%,振幅4.96%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Silo Pharma, Inc.、Virpax Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.涨幅较大,Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为2616.56%、1223.73%、355.64%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Virpax Pharmaceuticals, Inc.、Silo Pharma, Inc.,振幅分别为79.41%、61.68%、57.94%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231144941f7793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231144941f7793&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2450366326","title":"Marinus Pharmaceuticals, Inc.盘中异动 大幅上涨5.69%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450366326","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450366326?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:01","pubTimestamp":1720706499,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时01分,Marinus Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.69%。截至发稿,该股报1.30美元/股,成交量3.2799万股,换手率0.06%,振幅4.07%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.84%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc涨幅较大,Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Salarius Pharmaceuticals, Inc.较为活跃,换手率分别为496.11%、368.68%、274.42%,振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc,振幅分别为149.00%、82.31%、73.13%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220139af91debe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220139af91debe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2450815452","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.60%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450815452","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450815452?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:55","pubTimestamp":1720619748,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时55分,Marinus Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.60%。截至发稿,该股报1.32美元/股,成交量4.7256万股,换手率0.09%,振幅4.80%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.35%。其相关个股中,Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大,Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃,换手率分别为2019.31%、943.95%、581.00%,振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Longeveron Inc.,振幅分别为119.83%、62.50%、59.23%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102155499681b8d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102155499681b8d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.marinuspharma.com","stockEarnings":[{"period":"1week","weight":0.0317},{"period":"1month","weight":-0.0813},{"period":"3month","weight":-0.058},{"period":"6month","weight":-0.8669},{"period":"1year","weight":-0.814},{"period":"ytd","weight":-0.8804}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Marinus Pharmaceuticals, Inc.于2003年8月14日在特拉华州成立。该公司是一家临床阶段生物制药公司,专注于开发创新性神经精神疗法并将其商业化。该公司的临床阶段候选产品甘纳索龙是一种小分子,它是异孕烯醇的合成类似物,异孕烯醇是一种在中枢神经系统中产生的内源性神经甾体,调节大脑神经递质γ-氨基丁酸(GABA)。该公司对加那索龙的主要适应症是作为一种辅助或附加疗法,用于治疗成人癫痫患者部分发作(也称为局灶性发作)。该公司已在147名局灶性发作癫痫患者中完成了一项2期临床试验,表明与添加安慰剂的患者相比,在用药方案中添加加那索龙的患者癫痫发作率显著降低。Marinus Pharmaceuticals目前正在招募患者参加一项随机的2b期临床试验,该公司打算扩大该试验,以便在向美国食品和药物管理局(FDA)或欧洲药品管理局(EMA)提交的关于加那索龙治疗癫痫的注册文件中,作为其充分且受控的临床试验之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.037828},{"month":2,"riseRate":0.6,"avgChangeRate":-0.012045},{"month":3,"riseRate":0.5,"avgChangeRate":0.033633},{"month":4,"riseRate":0.5,"avgChangeRate":-0.069609},{"month":5,"riseRate":0.5,"avgChangeRate":-0.007141},{"month":6,"riseRate":0.5,"avgChangeRate":0.034813},{"month":7,"riseRate":0.6,"avgChangeRate":0.022118},{"month":8,"riseRate":0.454545,"avgChangeRate":0.02315},{"month":9,"riseRate":0.6,"avgChangeRate":0.189829},{"month":10,"riseRate":0.3,"avgChangeRate":-0.14351},{"month":11,"riseRate":0.4,"avgChangeRate":0.025431},{"month":12,"riseRate":0.6,"avgChangeRate":0.123461}],"exchange":"NASDAQ","name":"Marinus Pharmaceuticals","nameEN":"Marinus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Marinus Pharmaceuticals(MRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Marinus Pharmaceuticals,MRNS,Marinus Pharmaceuticals股票,Marinus Pharmaceuticals股票老虎,Marinus Pharmaceuticals股票老虎国际,Marinus Pharmaceuticals行情,Marinus Pharmaceuticals股票行情,Marinus Pharmaceuticals股价,Marinus Pharmaceuticals股市,Marinus Pharmaceuticals股票价格,Marinus Pharmaceuticals股票交易,Marinus Pharmaceuticals股票购买,Marinus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Marinus Pharmaceuticals(MRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}